2026 SCOPE X

May 18-19,2026
Boston, MA

Event: 2026 SCOPE X

Date: May 18-19,2026

Location: OMNI BOSTON HOTEL AT THE SEAPORT


SCOPE X is the newest addition to the trusted SCOPE 365 portfolio, created for clinical research executives and thought leaders who want to go beyond the surface and dive deeply into how advanced data strategies and artificial intelligence are transforming clinical research. This intimate, two-day gathering being held in Boston, the center of biopharma investment and innovation, brings together clinical research leaders, clin ops execs, heads of clinical data services, data scientists, technology innovators, AI start-ups, and experts for focused conversations on solving the industry’s most pressing challenges. This includes two programs: AI and Data Clinical Trial Optimization and AI Strategy and Business Value in Clinical Development, as well as an interactive Short Course.

Expect highly interactive sessions, detailed case studies, and collaborative problem-solving designed to spark actionable ideas you can implement in practice in these programs. You’ll connect with peers driving innovation in:
  • Integrating and optimizing diverse data sources

  • Implementing AI-ready data strategies

  • Applying AI for trial design, monitoring, and decision-making

  • Harnessing agentic AI for clinical trials transformation

  • Addressing AI-related governance, and ethical considerations

Our Booth Number: 18

We’d love to meet you at Booth 18—feel free to stop by and chat with us about how AI can accelerate your clinical and regulatory document workflows!


To request a meeting, fill out the form provided and a representative will be in contact soon to schedule.


Schedule a Meeting with Us

This is a required field.

By submitting this form, I accept to receive communications from AlphaLife Sciences in accordance with the Terms of our Privacy Policy

Thank You!

Thank you for requesting a meeting with our team! A representative will be in contact soon to schedule a convenient time.

Back Home